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Abstract
Community associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has become a major cause of skin and soft
tissue infections (SSTIs) in the US. We developed an age-structured compartmental model to study the spread of CA-MRSA
at the population level and assess the effect of control intervention strategies. We used Monte-Carlo Markov Chain (MCMC)
techniques to parameterize our model using monthly time series data on SSTIs incidence in children (#19 years) during
January 2004 -December 2006 in Maricopa County, Arizona. Our model-based forecast for the period January 2007–
December 2008 also provided a good fit to data. We also carried out an uncertainty and sensitivity analysis on the control
reproduction number, Rc which we estimated at 1.3 (95% CI [1.2,1.4]) based on the model fit to data. Using our calibrated
model, we evaluated the effect of typical intervention strategies namely reducing the contact rate of infected individuals
owing to awareness of infection and decolonization strategies targeting symptomatic infected individuals on both Rc and
the long-term disease dynamics. We also evaluated the impact of hypothetical decolonization strategies targeting
asymptomatic colonized individuals. We found that strategies focused on infected individuals were not capable of achieving
disease control when implemented alone or in combination. In contrast, our results suggest that decolonization strategies
targeting the pediatric population colonized with CA-MRSA have the potential of achieving disease elimination.
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between infected and non-infected individuals. However, the role
of these control interventions on CA-MRSA transmission dynamics remains poorly understood. In particular, in this paper we
asked if control strategies targeting symptomatic infected individuals were sufficient to achieve disease control in a population.
Although several mathematical models for MRSA transmission
in hospital settings, nursing homes, and other inpatient facilities
have been developed (e.g., [13–18]), there is a scarcity of
transmission models of MRSA and relevant epidemiological data
to parameterize them at the community level, but these could be
useful to elucidate the transmission dynamics and the effect of
control interventions on CA-MRSA. For instance, in [13], [14]
and [19], compartmental transmission models were developed to
study the invasion of CA-MRSA into hospitals and the likelihood
of coexistence between CA-MRSA and hospital-acquired (HA-)
MRSA. Moreover, HA-MRSA dynamics were exclusively studied
in both [16] and [17]. In these studies, health care workers were
modeled as vectors transmitting disease among patients (or
residents) with the goal of assessing the impact of quantifying the
effect of targeted control measures. Furthermore, most of these
modeling studies have assumed homogenous mixing, but recent
work has pointed to age-specific variation in MRSA infection risk
[4,20]. Hence, age-structured CA-MRSA transmission models at

Introduction
Background
Staphylococcus aureus is one of the most common bacterial
pathogens in humans and the most frequent cause of skin and
soft tissue infections (SSTIs) [1]. Strains of health care-associated
methicillin-resistant S. aureus (HA-MRSA) were first identified
among hospitalized patients in 1960 [2] and dominated MRSA
infections until late 1980s. Since the early 1990s, there has been a
dramatic increase in community-associated MRSA (CA-MRSA),
which is now endemic at unprecedented levels in many regions in
the US [3–6]. This increase in CA-MRSA appears to have
regional variation and is more pronounced in children compared
to adults [4,5,7]. Cases of HA-MRSA and CA-MRSA are
characterized by significantly different epidemiological and
microbiological features [8].
Evidence indicates that CA-MRSA infections result from
physical contacts with MRSA carriers at home, community
facilities such as gyms, nursing homes, or kindergartens [9]. In
addition to regular treatment of the actual infection of the infected
individuals, typical intervention strategies against CA-MRSA
related SSTIs focus on pharmaceutical treatment via decolonization using mupirocin [10–12] and reductions in contact rates
PLOS Computational Biology | www.ploscompbiol.org
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Author Summary

Methods

Community associated methicillin-resistant Staphylococcus
aureus (CA-MRSA) is a bacteria that causes skin infections
in the US. We developed a mathematical model of CAMRSA transmission among different age groups at the
population level. We parameterized the model using
monthly time series data on number of SSTIs in children
during the period January 2004–December 2006 in
Maricopa County, Arizona. Our model-based forecast to
additional time series data covering the period 2007–2008
yielded a good fit to data. Using our calibrated model, we
calculated that an infected individual generates on
average 1.3 infected people in a totally susceptible
population in the study area. We assessed the impact of
intervention strategies including reductions in contact
rates between infected and non-infected individuals and
the effect of decolonization strategies aimed at infected
individuals by drug treatment, and found that neither of
the two strategies when implemented alone or in
combination were able to control the disease. In contrast,
we found that decolonization strategies targeting the
pediatric population colonized with CA-MRSA have the
potential of achieving disease elimination.

Model description
We developed an SEIS (Susceptible-Exposed-Infected-Susceptible) transmission model that incorporates age heterogeneity in
contact rates, infectiousness, and decolonization treatment rates.
Our model also keeps track of individuals with past infections
because these individuals have been observed to have a higher rate
of infection compared to those with no past infections [24], and we
are interested in assessing the effect of age-specific variation in
infectiousness and the effect of targeted interventions. Let S0a , C0a ,
I0a be the respective number of susceptible, colonized (asymptomatic), and infected (symptomatic) individuals in age group a
(a~1,2, . . . ,n) with no prior infections. Similarly, let S1a , C1a , I1a
be the corresponding epidemiological states for individuals with
prior infection history. The schematic view of transitions among
the 6 epidemiological states in our model for each age group is
shown in Figure 1. Mupirocin is used for decolonization of CAMRSA patients who have been treated by other antibiotics.
Hence, in our model only decolonized individuals coming from
the infected compartments experience the additional decolonization rate d1 . Our transmission model is given by the following
system of differential equations:

the community level and tailored to local epidemiological data
could increase our understanding of the transmission dynamics of
CA-MRSA and the impact of routine and novel intervention
strategies.
Here we developed and parameterized an age-structured
compartmental transmission model to study the transmission
dynamics of CA-MRSA at the population level and evaluate the
effect of various intervention strategies. To calibrate the model, we
employed a unique dataset Dataset S1) covering several years of
SSTIs incidence during the period January 2004–December 2006
in Maricopa County, Arizona. We also used additional incidence
data for subsequent years 2007–2008 for validation purposes.
Based on our calibrated model, we estimated the reproduction
number denoting the average number of secondary infections
generated by primary infectious individual [21–23] and evaluated
the effect of contact rate reductions aimed at infected individuals
owing to awareness of infection as well as decolonization treatment
strategies targeting symptomatic infected individuals or the general
(asymptomatic) colonized subpopulation.

dS0a
~{la S0a zd0a C0a zma Na {ma S0a ,
dt

ð1aÞ

dC0a
~la S0a {d0a C0a {t0a C0a {ma C0a ,
dt

ð1bÞ

dI0a
~t0a C0a {ca I0a {ma I0a ,
dt
dS1a
~{la S1a z(d0a zd1a )C1a {ma S1a ,
dt

ð1dÞ

dC1a
~ca (I0a zI1a )zla S1a {(d0a zd1a )C1a
dt

ð1eÞ

{t1a C1a {ma C1a ,
dI1a
~t1a C1a {ca I1a {ma I1a
dt

Epidemiological data
We obtained detailed data on CA-MRSA infections from the
Center for Health Information Research (CHIR), which is a
university-community partnership between Arizona State University and several Arizona providers, insurers and employers. The
dataset (Dataset S1) comprises records on hospitalization and
outpatients visits by children and teenagers (age#19 years)
enrolled in the Medicaid program of Arizona from January 1,
2004 to December 31, 2008. We extracted records of all
encounters diagnosed with skin or soft tissue infection (SSTI)
based on ICD 9 codes (680.xx-682.9x). Each record contains
information about the type of infection (first-time infection or
recurrent infection), age group, month and year of hospital or
clinic visit, and whether the patient was treated with mupirocin.
Our data are based on SSTIs related infections, with a stationary
fraction of MRSA-related infections during our study period [24].
We also obtained population data by age groups for our study
setting. An extended data description is given in Text S1.

ð1fÞ

for a = 1, 2, …, n. The spontaneous (natural) decolonization rate
per unit of time (month is denoted by d0) and is assumed to be the
same for all colonized individuals independently of their infection
history. The progression rate from colonized to infected is t0 for
those colonized for the first time and t1 for those with prior
t1
infections, where t1.t0, with a relative risk factor s~ w1.
t0
Infected individuals in compartments I0 and I1 progress to the
colonization (with prior infections) stage (C1) following antibiotic
treatment at a common cure rate c. Further, treatment for
decolonization aimed at C1 transfers individuals to compartment
S1 at a decolonization rate d1. Both colonized and infected
individuals contribute to the force of infection, which is given by

la ~

n
X
waa bC (C0a zC1a )zwaa bI (I0a zI1a )
a~1
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where waa denotes the contact rate for the colonized and infected
individuals with susceptible individuals in age group a. Moreover,
bC and bI are the probabilities of transmission per contact
(contagiousness) for colonized and infected individuals, respectively, which are assumed to be invariant across age groups. Because
infected individuals are assumed to be more infectious than
colonized individuals, bC vbI , with a relative contagiousness
b
factor f ~ C [(0,1). Further, m is the population immigration/
bI
migration rate and Na ~S0a zC0a zI0a zS1a zC1a zI1a is the
total population size with new recruits into the susceptible
population with no past CA-MRSA infection history.

initial (or most likely) values and ranges were obtained from a
literature review while others were proposed by primary analysis of
our epidemiological data. Specifically, we estimated the decolonization treatment coverage (or rate) (denoted as dca , a[f1,2, . . . ,6g)
for each age group over the years by calculating the percentage of
patients who were prescribed mupirocin (see Text S1 for details).
The overall age-specific decolonization rate, d1a , is then set to be
the product of the treatment efficacy (percentage of successfully
decolonized people among those who were prescribed mupirocin,
denoted by ed in Table 1), the age-specific treatment coverage dca
(values are given by Table S1), and the reciprocal of the duration
of the drug effect (about 2 weeks [10]). Moreover, we assumed
higher transition rates from colonized to infected states for both
first-time and recurrent infections for individuals 0–4 and 15–
19 yrs., as there was a significantly higher number of cases for
these two groups in our epidemiological data, which is in
agreement with other empirical studies[27,28]. That is,
~
ti ~½f1 ,1,1,f4 ,1,1  ti for i~0 and 1, where f1 and f4 are the
relative factors, and t0 (t1 ) is the progression rate from colonized to
infected for first-time (recurrent) infections for other age groups.

Parameters
Age-specific contact rates. We stratified the population in
our model into six age groups (years), 0–4, 5–9, 10–14, 15–19, 20–
59, and 60+ yrs. The first four refined age groups are referred to as
pediatric groups in this paper and are defined consistently with the
age groups attending daycare/home-care, elementary school,
junior high school, and high school in the US, respectively, as
we are primarily interested in capturing the CA-MRSA transmission dynamics among young age groups. Contact rates across age
groups were adapted from data on physical contacts previously
derived from population surveys that were conducted in eight
European countries [25] by collapsing the age groups 20–24, …,
55–59 into one adult group of age 20–59, and groups 60–64,65–
69,70+ into a senior group 60+ yrs. following a similar approach as
in [26] (Figure 2).
Epidemiological parameters. The basic epidemiological
parameters and baseline values are listed in Table 1. Most of the

Model calibration, validation and forecast
We calibrated our model given by System 0 with time series
data of first time and recurrent infections for age groups 0–4, 5–9,
10–14, and 15–19 yrs. from January 2004 to December 2006 and
estimated the unknown epidemiological parameters (Table 1). For
this purpose, we assumed as initial conditions that all people in the
population were free of past infections in January 2004 (first time
point). That is, we set to 0 the initial value for S1a ,C1a ,I1a , for
a[f1,2, . . . ,6g. The initial number of people with first-time

Figure 1. Flow diagram for the compartment model of the transmission dynamics of CA-MRSA for each age group. S0 is the number
of susceptible people with no prior colonization with CA-MRSA, C0 is the number of people colonized for the first time, and I0 are the number of
people with first-time infection. S1 , C1 , I1 are individuals with a history of past infections. People with infections from both groups (I0 and I1 )
become colonized (C1 ) with a common cure rate (c). Further decolonization treatment (e.g. mupirocin) clears individuals and progress to the
susceptible state (S1 ). Susceptible individuals with or without past infections progress to the colonized stage with the same force of infection l, but
their progression rate from colonized to infected stages are different (t0 vs t1 , respectively). Colonized individuals without past infections have only
spontaneous decolonization with rate d0 while those with past infections are subject to additional decolonization treatment with rate d1 . m is the
population immigration/migration rate per month.
doi:10.1371/journal.pcbi.1003328.g001
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Figure 2. Monthly contact rates among age groups (waa ). Calculated from survey data on physical contacts from Mossong et al. [25].
doi:10.1371/journal.pcbi.1003328.g002

infections in adult groups, I05 and I06 , as well as the percentage of
completely susceptible people in each age group at the beginning
of 2004, S0p (common across the age groups), were taken as
unknown parameters to be estimated.
We employed a delayed rejection adaptive Metropolis-Hastings
(DRAM) algorithm in a Markov-Chain Monte-Carlo (MCMC)
simulation framework [29] to estimate unknown model parameters.

We used the widely-used MCMC package coded in Matlab
(available from: http://helios.fmi.fi/,lainema/mcmc/) (Text S3).
For each estimated parameter we assumed uniform prior
distributions with range values as given in Table 1. Posterior
distributions for each parameter were obtained from the resulting
Markov chains [30]. Next, we selected a random sample of size 500
from the Markov chain of parameters to assess parameter

Table 1. Epidemiological parameters: definition, symbol, and initial value and range used in parameter estimation using the
MCMC technique.

Definition, unit

Parameter

Initial Value

Range

Reference
[44], proposed

probability of transmission per contact with infected

bI

0.0017

0.0009–0.0025

relative contagiousness factor for colonized to infected

fb

0.25

0–0.5

[24]

spontaneous decolonization rate, month21

d0

0.09

0.02–0.8

[45,46]

efficacy of decolonization by mupirocin

ed

0.8

0.5–1

[47]

progression rate from colonized to infected (baseline), month21

t0

0.035

0.01–0.15

[24,48]

relative risk of infection (from colonized) for 0–4 age group

f1

1.6

1.0–2.0

proposed

relative risk of infection (from colonized) for 15–19 age group

f4

1.4

1.0–2.0

proposed

relative risk of progression rate from colonized to infected due to previous infection

ft

2.5

2.0–8.0

[49]

cure rate (1/(infection duration)), month21

c

1

0.25–1.5

[18,24]

immigration/migration rate, month21

m

0.0029

-

[50]

‘Proposed’ in reference column means proposed by primary analysis of the data.
doi:10.1371/journal.pcbi.1003328.t001
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uncertainty. For model validation, we compared our calibrated
model forecast for two subsequent years of time series data covering
the period 2007–2008.
Latin Hypercube Sampling (LHS) and Partial Rank Correlation
Coefficient (PRCC) techniques [31] were used for sensitivity
analysis to assess the impact of control strategies targeting different
age groups on the reproduction number Rc . LHS provides
remarkable efficiency in drawing a highly representative random
sample of small size from a multi-dimensional distribution[32,33].
The magnitude of PRCC quantifies the importance of individual
parameters, with the sign of the PRCC value indicating the
specific qualitative relationship between the input and the output
variable. That is, positive values of PRCC implies that increasing
values of the input variable lead to increasing values of the output
variable. Since a PRCC indicates the degree of the monotonicity
between a specific input variable and a specific output variable,
only input variables that are monotonically related to the output
variable are included in this analysis [32,34]. Hence, we examined
the scatterplots between Rc and each parameter to assess the
monotonicity assumption.
We set out to analyze the effectiveness of the various types of
control interventions including typical interventions targeting
symptomatic infected individuals and novel decolonization
strategies focused on the colonized reservoir pediatric population.
Specifically, we evaluated reductions in contact rates by infected
individuals due to personal awareness of infection. We also
assessed the impact of decolonization treatment of infected people
following regular antibiotic treatment of MRSA infections.
Finally, we examined the possibility of disease elimination by
hypothetical decolonization treatment strategies targeting colonized people (in compartment C0 ). We modeled the first
intervention by using an age-specific parameter, ga ,
a[f1,2, . . . ,6g, to denote the relative reduction in contact rates
between different age groups. Thus, the force of infection given
by Equation (1g) becomes

la ~

n
X
waa bC (C0a zC1a )z(1{ga )waa bI (I0a zI1a )
:
N
a~1

Table 2. Statistics for estimated parameters based on the
Markov chain generated by the adaptive Metropolis Hastings
algorithm with 2004–2006 data.

mean

std

geweke

bI

0.0021

0.00026

0.70

fb

0.40

0.081

0.48

d0

0.19

0.058

0.31

ed

0.59

0.082

0.85

t0

0.014

0.0017

0.78

f1

1.85

0.075

0.92

f4

1.93

0.043

0.94

ft

1.80

0.14

0.93

c

1.18

0.21

0.53

C0p ~1{S0p

0.093

0.0047

0.92

I05

459

90

0.78

I06

270

47

0.78

The geweke index closes to 1 means good convergence of the MCMC chain for
that parameter.
doi:10.1371/journal.pcbi.1003328.t002

Uncertainty and sensitivity analysis for Rc
We estimated the control reproduction number Rc using
Equation (S2). which we derived using the next generation matrix
method [35,36] (Text S2).Parameters bI , fb , d0 , t0 , ft and c
satisfied the monotonicity assumption and the corresponding
PRCCs are shown in Figure 4B. We found that Rc is most
sensitive to the parameters t0 (progression rate from colonized to
infected) followed by c (reciprocal of the duration of being
infected). Rc is also fairly sensitive to d0 (spontaneous decolonization rate). All of them are significant from zero at the 0.001 level
according to their p-values.

ð2Þ

Evaluating the effect of intervention strategies
The effectiveness of reducing contact rates by infected
individuals. In order to assess the impact of contact rate

The decolonization treatment targeting symptomatic infected
individuals was modeled by varying the decolonization
treatment coverage dca (in ½0,1), for a[f1,2, . . . ,6g. The effect
of decolonization treatment for colonized people was modeled
by adding an additional age-specific rate dia , a[f1,2, . . . ,6g, to
the spontaneous decolonization rate d0 , as the new transition
rate from C0 to S0 (Figure 1). Parameter dia is the product of
decolonization coverage (age-specific) and reciprocal of duration of drug effect (2 weeks [10], common across age groups)
by assuming perfect drug efficacy. We estimated the associated
reduction in Rc and determined whether infections approached zero as we varied the age-specific decolonization
coverage.

reductions by infected individuals across different age groups, we
used mean estimates of model parameters as given in Table 2. We
drew a random sample of parameters ½g1 , . . . ,g6  of size 100 from
its 6-dimensional uniform distribution using LHS to calculate the
distribution of Rc and the corresponding PRCCs of each of ga ’s.
As expected, the greater the reduction in contact rate by infected
individuals the higher the reduction in Rc , with the age group 10–
14 yrs being slightly more influential on reducing Rc relative to
other age groups. Specifically, we estimated the reduction levels in
Rc as we decreased the contact rates from 0 to 100% among
infected individuals aged 10{14 yrs (Figure 5A2) or across all age
groups (Figure 5A3). For instance, mean Rc was reduced by only
1.0% when infected individuals aged 10–14 yrs did not make
contacts with other individuals while Rc was reduced by 4% in the
scenario that all infected individuals across all age groups did not
make contacts with others.

Results
Model-based estimates

Evaluating the effect of decolonization treatment on
infected individuals. To examine the effect of decolonization

Model parameter estimates and their corresponding geweke
indices are shown in Table 2. Overall the model yielded a good fit
to the incidence curve covering the period 2005–2006 albeit three
of the parameter estimates did not achieve high convergence based
on their geweke indices (fb , d0 and c) (Figure 3). Moreover, the
model forecast for two subsequent years 2007–2008 tracked
closely the additional incidence data.
PLOS Computational Biology | www.ploscompbiol.org

Parameter

treatment strategies targeting symptomatic infected individuals, we
quantified the sensitivity of each age-specific decolonization
coverage dca on Rc . We found that All PRCCs across age groups
for dca s followed the same pattern (Figure 5B1) except for dc6 , the
decolonization treatment coverage for the 6th age group (60+ yrs.),
5
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Figure 3. Model fit to MRSA infection data using MCMC toolbox. The wider band shows 95% probability limits for individual observations,
the darker narrower band shows 95% probability limit for mean prediction and the black curve in the middle is the median prediction. Little squares
are data points; the vertical dashed line indicates the calibration period (2004–2006) and the validation period (2007–2008).
doi:10.1371/journal.pcbi.1003328.g003

which showed no monotonic relation with Rc (not shown in
Figure 5B1). The mean Rc decreased by 2.1% when all infected
individuals aged 10–14 yrs were treated by decolonization drugs
for regular antibiotic treatment for CA-MRSA infections
(Figure 5B2) while Rc was reduced by 7.8% when all infected

PLOS Computational Biology | www.ploscompbiol.org

individuals across all age groups were treated by decolonization
drugs (Figure 5B3). We found that decolonization treatment
strategies targeting symptomatic infected individuals were not
sufficient to achieve disease control. Simulations of decolonization
treatment strategies targeting all infected individuals in pediatric
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Figure 4. Uncertainty and sensitivity analyses on the control reproduction number Rc . Histogram of Rc (A) and PRCC of parameters with
Rc (B) with parameter uncertainty (based on a random sample of size 500 of Markov chain for parameters).
doi:10.1371/journal.pcbi.1003328.g004

individuals in any single age group was not enough to achieve
disease control. However, by exploring decolonization treatment
targeting combinations of two pediatric age groups, we found that
decolonization treatment targeting colonized individuals in age
groups 5–9 and 10–14 yrs. achieved Rc v1 whenever coverage
levels w25% (Figure 8). By targeting colonized people across 4
pediatric age groups, we also found that the minimum decolonization treatment coverage necessary to achieve Rc v1 was 5%.
The long-term disease dynamics forecasts with decolonization
treatment coverage at 30% implemented continuously starting in
year 2009 on age groups 5–9 and 10–14 yrs. and across all
pediatric groups are shown in Figure 9. Findings indicated that
targeting individuals aged 5–14 yrs. required 20 years to achieve
disease elimination while disease control could be achieved within
5 years when the intervention was focused on all pediatric groups.

age groups or across all age groups are shown in Figure 6. We
found that recurrent infections were essentially brought under
control, but first-time infections remained well above zero even
when all infected individuals across all age groups underwent
decolonization treatment.
Effectiveness of combinations of the two strategies
targeting symptomatic infected people. We assessed if a

combination control strategy that includes reduction in contact
rates by infected individuals with others and decolonization
treatment for infected individuals was capable of achieving disease
control. The effective values of Rc as a function of different
reduction levels in contact rates by infected individuals and
different levels of decolonization treatment coverage targeting
symptomatic infected individuals across all age groups are shown
in Figure 7. Rc was no less than 1.18 under the combination of two
strategies regardless of their intensity levels. In addition, the long
term effect of single or combined intervention strategies on disease
levels are illustrated in Table 3. It shows that decolonization
treatment for the infected reduced much more total infections in
the pediatric population than reducing contacts of infected people
did, and a combination control strategy implementing both
intervention strategies was not sufficient to achieve disease
eradication.

Discussion
We have developed and parameterized the first age-structured
model of the transmission dynamics of MRSA transmission at the
community level using data on skin and soft tissue infections in
children and teenagers who were enrolled in the Medicaid
Program in Maricopa County, Arizona. Our compartmental
epidemic model includes age heterogeneity in contact rates,
infectiousness, and decolonization treatment rates, and keeps track
of individuals with past infection history. We estimated the control
reproduction number at 1.3 with 95% confidence interval [1.2,
1.4]. Sensitivity analysis of Rc on the model parameters revealed
that Rc is most sensitive to the parameters t0 (progression rate
from colonized to infected) followed by c (reciprocal of the

Evaluating the impact of decolonization treatment
strategies targeting colonized people. Whereas routine

intervention strategies targeting symptomatic infected individuals
were not found to be capable of achieving disease control, we also
evaluated the impact of hypothetical intervention strategies
targeting colonized (asymptomatic) individuals (compartment C0
in Figure 1). We found that treatment of colonized asymptomatic
PLOS Computational Biology | www.ploscompbiol.org
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Figure 5. PRCC and Rc under different intervention strategies. Upper panel: PRCC of ga (a[f1,2, . . . ,6g, level of contact reduction in age
group a), with Rc based on a sample of size 100 using LHS (A1); Rc for different levels of contact reduction under uncertainty of other model
parameters (A2); and Rc for different level of population-wide contact reduction under the uncertainty of other parameters(A3). Lower panel: PRCC of
dca (a[f1,2, . . . ,6g, decolonization treatment coverage in age group a), with Rc based on a sample of size 100 using LHS (B1); Rc for different levels of
decolonization treatment coverage under uncertainty of other model parameters (B2); and Rc for different levels of population-wide decolonization
treatment coverage under the uncertainty of other parameters (B3).
doi:10.1371/journal.pcbi.1003328.g005

combined strategy was able to achieve Rc v1. We also forecasted
short-term disease dynamics in the presence of both types of
interventions strategies starting in 2009. Our results suggest that
reductions in contact rates by infected people has little effect on the
disease prevalence, and that neither of the two strategies was
capable of achieving disease control particularly among first-time
infections. Given that these two intervention strategies are the
most widely practiced (intuitively and clinically), our model-based
results provide an explanation to the persistent levels of CAMRSA in many US regions over 20 years since its first appearance
[3–6]. We also tested the effectiveness of some hypothetical
decolonization treatment strategies targeting asymptomatic colonized people. We found that Rc could be reduced below 1 when

duration of being infected) and d0 (spontaneous decolonization
rate). Using our calibrated model, we found that typical strategies
focused on infected individuals were not capable of achieving
disease control when implemented alone or in combination. In
contrast, our results suggest that novel decolonization strategies
that target the general pediatric population colonized with CAMRSA have the potential of achieving disease elimination.
We performed numerical simulations to explore the impact of
various feasible intervention strategies such as reductions in
contact rates by infected people owing to personal awareness of
infection and effect of decolonization treatment targeting symptomatic infected individuals belonging to specific age groups or
across the entire population. We found that neither a single or

PLOS Computational Biology | www.ploscompbiol.org

8

November 2013 | Volume 9 | Issue 11 | e1003328

Modeling CA-MRSA Transmission

Figure 6. Model prediction for first-time and recurrent infections for pediatric groups until December 2023 with mean parameter
values and different decolonization treatment coverage after 2008. 100% coverage for the first 4 age groups and 0 for adult groups (slim
lines); 2). 100% coverage for the whole population (bold lines). The age-specific decolonization treatment coverage for till 2008 are time-dependent
step functions with extreme values given by Table S1 for 4 pediatric groups and 0 for 2 adult groups.
doi:10.1371/journal.pcbi.1003328.g006

the treatment was focused on 5–9 and 10–14 yrs. age groups
with coverage at 25%, and an even smaller coverage (5%) was
sufficient when all pediatric groups groups were targeted. Longterm forecast of the infections showed that disease elimination
is feasible within 5 years through decolonization treatment at
30% of colonized people in the pediatric population starting in
2009.
Compared with published models on MRSA transmission, our
model is novel in several ways. First, our model accounts for
transmission in a heterogeneous population based on age-specific
contact rates calibrated using survey data on physical contacts
[25]. This enables our model to capture much more essential
elements of the complex MRSA transmission problem and test
the effect of different control strategies that target different age
groups. Second, our model was calibrated and provided a good
fit to time series data using solid estimation techniques rather
than solely relying on assumed parameter values from the
literature. It is worth mentioning that our estimate of the control
reproduction number at 1.3 is in line with that assumed in prior
studies (e.g., [37]). Moreover, it important to note that while our
model incorporates key features of the transmission process
including a realistic population contact structure and dominant
features of MRSA epidemiology, there are many limitations to
policy models with respect to the incorporation of bio-medical,
operational, political, and economic features. No one model can
PLOS Computational Biology | www.ploscompbiol.org

claim to incorporate all assumptions and features given the
limited data available to calibrate them. We believe our
transmission model could be useful to evaluate further control
scenarios and formulate rational policy based on the best
available evidence.
There are limitations to note about our model calibration.
Some of the Markov chains did not converge perfectly within
10000 steps in terms of the geweke index. However, our
objective here was to find reasonable values of parameters so
that our model captured qualitatively the overall trend of the
age-specific time series data. In this sense, the MCMC
algorithm worked much better than other sampling methods
(e.g., Latin Hypercube Sampling or simple random sampling
with repetition). Moreover, we also calculated the Rsquared(R2 ), a widely-used index for goodness of fit for a
general model, for each of the eight output variables, and it
turned out that the R2 s for first-time infections were much
poorer (less than 0.5) than those for the recurrent infections
(greater than 0.7). Hence, our model did a better job in
modeling recurrent infections than first time infections. Of
note, our model described by System (1) does not account for
seasonality patterns [38], which may explain a significant
fraction of variation in data that remained unexplained by the
model. Moreover, we did not account for the changing medical
practice as our understanding of this pathogen has increased
9
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Figure 7. Mean value of Rc for a combined strategy of with different levels of reduction in contact of infected individuals (ga ) and
decolonization treatment coverage the infected (dca ) in all age groups under parameter uncertainty.
doi:10.1371/journal.pcbi.1003328.g007

Table 3. Model-based forecast of the number of first-time infections (I0a )and recurrent infections (I1a ) for the first age groups
(a[f1,2,3,4g), and reduction of total infections in the pediatric population (0–19 years) compared with baseline (no intervention) at
the end of 2023 under different population-wide intervention strategies.

Strategy

I01

I02

I03

I04

I11

I12

I13

I14

total reduction

Baseline

150

133

137

143

182

146

172

312

0

Strategy 1

128

116

121

126

124

104

125

214

23%

Strategy 2

26

26

28

27

3

1

1

4

91%

Strategy 1 and 2

19

19

20

20

2

1

2

2

94%

Strategy 1: 100% reduction in contact of infected with others; Strategy 2: decolonization treatment for all infected.
doi:10.1371/journal.pcbi.1003328.t003
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Figure 8. Mean Rc with different levels of decolonization treatment coverage for colonized people in various combinations of two
of pediatric groups. The error bars are based on standard deviations of Rc s under parameter uncertainty.
doi:10.1371/journal.pcbi.1003328.g008

In summary, our model indicates that intervention strategies
targeting only infected people, either by reducing their contact
frequency with healthy people or by pharmaceutical decolonization are not capable of eliminating CA-MRSA infections at the
population level. By contrast, substantial reductions in the
prevalence of HA-MRSA could be achieved via contact
reductions via patient isolation, enhanced hand hygiene and
screening and health-care worker cohorting strategies (e.g., [43]).
Our control scenarios based on decolonization treatment
strategies that target asymptomatic colonized individuals indicate
that finding a cost-effective method to locate colonized individuals and conducting decolonization treatment on a limited
fraction of them could prove to be an effective intervention.
However, the possibility of resistance emerging from increased
use of mupirocin cannot be overemphasized. Future modeling
studies could be carried out to to evaluate the effect of strategies
aimed at reducing the impact of resistance emerging from largescale use of mupirocin. Moreover, further work should focus on
the collection of morbidity data and quantification of the attack
rates and transmission dynamics of CA-MRSA in other world
settings with different socio-economic and climatic characteristics.
While our transmission model is based on key epidemiological
features of CA-MRSA including age-specific heterogeneity in

since 2004. The infection duration decreased over these years
as the appropriate antibiotics changed from second line
medications to first line medications [39–41]. Therefore the
model prediction might have overestimated the infection
prevalence.
Our dataset itself has several limitations. First, our data
correspond to general SSTIs which may not be directly related
to CA-MRSA. However, it has been observed from microbiological analyses that the fraction of MRSA-related SSTIs remained
stationary among the total SSTIs in our study population for our
study period [24]. Given that it will be difficult to truly determine
the exact cases of MRSA-related SSTIs and their microbiological
spectrum at the population level, our data set is the best among
those available. Second, the target population of the data set
corresponds to the children and young adults in the Medicaid
program in Maricopa County, AZ. It is important to note that
patients under Medicaid coverage belong to a lower income
population, where the rate of infection has been described to be
higher than that of the general population[5,42]. Hence, our
model prediction likely overestimates the prevalence in the overall
population in Maricopa County. Further studies are needed to
shed light on whether our findings can be generalized to other
settings.
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Figure 9. Long-term forecast of CA-MRSA infections in the pediatric groups under decolonization treatment strategy targeting
colonized people with 30% coverage in different age groups. 5–9 and 10–14 yrs. age groups (upper panel); all pediatric groups (lower panel).
doi:10.1371/journal.pcbi.1003328.g009

Text S1 Description of Dataset S1 and data manipulation.

contact rates, infectiousness and decolonization treatment rates,
predictions from more elaborate models that incorporate, for
instance, seasonality in transmission efficiency or a more detailed
picture of the transmission process (e.g., household level
transmission models) could be undertaken in future work as
relevant epidemiological data become available.
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